Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. (Q50964825)
Jump to navigation
Jump to search
scientific article published in March 1997
Language | Label | Description | Also known as |
---|---|---|---|
English | Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. |
scientific article published in March 1997 |
Statements
Usefulness of detection of minimal residual disease by 'hypermetaphase' fluorescent in situ hybridization after allogeneic BMT for chronic myelogenous leukemia. (English)
1 reference
Champlin R
1 reference
Giralt S
1 reference
Seong D
1 reference
Fischer H
1 reference
Hayes K
1 reference
Glassman A
1 reference
Arlinghaus R
1 reference
Xu J
1 reference
Kantarjian H
1 reference
Siciliano M
1 reference
1 March 1997
1 reference
19
1 reference
6
1 reference
565-570
1 reference
Identifiers
1 reference